Company intelligence / Profile preview

BroadMed

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

BroadMed (Beijing) Medical Technology Co., Ltd. is a specialized biotechnology company that develops and manufactures high-quality reagents and kits for life science research and molecular diagnostics. The company's product portfolio includes comprehensive solutions for nucleic acid extraction and purification, PCR and qPCR amplification, and Next-Generation Sequencing (NGS) library preparation. BroadMed serves a global customer base across academic institutions, clinical laboratories, and the pharmaceutical industry, providing essential tools for genomic and proteomic research. With a focus on innovation and stringent quality control, the company has established itself as a significant supplier in the molecular biology tools market.

Industry: Molecular Diagnostics

Beyond the preview

Go deeper on BroadMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BroadMed.

Explore the full profile